Private Policy
© 2024
Why Multimerize?
Monomeric antigens can be poorly immunogenic, and its multimerisation can confer single shot seroconversion and better Ab responses, due to improved drainage to lypmh nodes and certain VLPs packaging TLR adjuvants.
Furthermore oriented antigen display can produce better quantitative and qualitative Abs than random display.
Why use Site-Specific Conjugation to Multimerize?
Use our technology to orient the display of any antigen or agonist of choice onto a nanoparticle for improved outcome. Our technology is simple, fast and robust, accelerating the research and development pipeline of your Prophylactic or Therapeutic Vaccine strategies.
Provide oriented antigen display needed for efficient B-cell receptor cross-linking
No inter cross-linking of nanoparticles
No chemical modification of internal residues
Private Policy
© 2024
Site-specific chemistries,
payloads & ready-made
conjugates
Explore our bioconjugation toolbox and Purchase off-the-shelf products developed for your early stage research.
